An Interest In:
Web News this Week
- April 24, 2024
- April 23, 2024
- April 22, 2024
- April 21, 2024
- April 20, 2024
- April 19, 2024
- April 18, 2024
Some of Our Sources
- Slashdot
- Smashing Magazine
- Creative Curio
- Fuel Your Creativity
- Wal You
- CSS Tricks
- Willems Lab
- Dev To
- Hashedout
- TechPowerUp
Help Webnuz
Referal links:
March 21, 2012 10:57 am GMT
Index Ventures may be best known on these pages for its technology investments, but today it launched a new fund that points to how the company is willing to put its money into other examples of strong innovation. The life sciences fund will see Index put in $100 million of its own capital, and have it matched by $50 million each from big pharma leaders GlaxoSmithKline and Johnson & Johnson.Much like the new $400 million fund from Iris Capital, Orange and Publicis, this fund is all about bringing in major players into an environment where they can make more investments into the technologies and services that could well be the future of their industries, but have possibly been too difficult to track and engage with up to now. This time around, the focus is not tech per se, but promising, early-stage R&D innovation in health.
Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/8CeMrFbpAn4/
Index Launches Its First Life Sciences Fund: $200M And Partnering With Glaxo and Johnson & Johnson
Index Ventures may be best known on these pages for its technology investments, but today it launched a new fund that points to how the company is willing to put its money into other examples of strong innovation. The life sciences fund will see Index put in $100 million of its own capital, and have it matched by $50 million each from big pharma leaders GlaxoSmithKline and Johnson & Johnson.Much like the new $400 million fund from Iris Capital, Orange and Publicis, this fund is all about bringing in major players into an environment where they can make more investments into the technologies and services that could well be the future of their industries, but have possibly been too difficult to track and engage with up to now. This time around, the focus is not tech per se, but promising, early-stage R&D innovation in health.Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/8CeMrFbpAn4/
Share this article:
Tweet
View Full Article
Techcrunch
TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.More About this Source Visit Techcrunch